Jan Haavik is a medical doctor who graduated from the University of Bergen. After completion of an 18 month clinical internship in internal medicine, surgery and general practice, he started research in biochemistry, biophysics and molecular biology. He defended his dr. med./phd degree in biochemistry in 1989 and was appointed as full professor at Department of Biochemistry and Molecular Biology in 1993. During his entire career he has combined teaching, basic and translational neuroscience research with full-time or part-time clinical duties. He is a board certified specialist of adult psychiatry. From 2002 he has been working a senior consultant in psychiatry at Haukeland University hospital, with a special focus on ADHD and affective disorders. He is leading the Neurotargeting Research group and the Center of Neuropsychiatric Disorders, dedicated to exploring new treatment targets for neuropsychiatric disorders. He is involved in multiple international collaborative projects. Interspersed with his work in Norway, he has had multiple stays research institutions in Sweden, Scotland, Germany, France, the United States and the Netherlands.
- 2019. Tyrosinemia Type 1 and symptoms of ADHD: Biochemical mechanisms and implications for treatment and prognosis. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 1-11.
- 2019. Serine 19 phosphorylation and 14‐3‐3 binding regulate phosphorylation and dephosphorylation of tyrosine hydroxylase on serine 31 and serine 40. Journal of Neurochemistry. 1-19.
- 2019. Patterns of psychiatric comorbidity and genetic correlations provide new insights into differences between attention-deficit/hyperactivity disorder and autism spectrum disorder. Biological Psychiatry. 46 pages.
- 2019. Parent-offspring recurrence of ADHD.
- 2019. Parent-of-origin and maternal effects in attention deficit hyperactivity disorder.
- 2019. Nordic OCD & Related Disorders Consortium: Rationale, design, and methods. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 1-13.
- 2019. Effect of disease-associated SLC9A9 mutations on protein–protein interaction networks: implications for molecular mechanisms for ADHD and autism. ADHD Attention Deficit and Hyperactivity Disorders. 91-105.
- 2019. Brain imaging of the cortex in ADHD: A coordinated analysis of large-scale clinical and population-based samples. American Journal of Psychiatry. 531-542.
- 2019. Attention-deficit/hyperactivity disorder and autoimmune diseases. Etiological relationships and therapeutic possibilities.
- 2019. Attention-deficit hyperactivity disorder shares copy number variant risk with schizophrenia and autism spectrum disorder. Translational psychiatry. 1-9.
Jan Haavik completed his medical education at the University of Bergen in 1983. As a student, he started his research career in biochemistry, biophysics and molecular biology. He conducted a tour of Bergen and the municipalities of Agder, graduated from the University of Bergen in 1989, and was employed as a professor, 34, at the present Institute of Biomedicine in 1993. In the period 1986-2014 he had nine shorter and longer research stays at outstanding research institutions in Sweden, Scotland, Germany, France, the United States and the Netherlands. From 2002 he has had a 20% position as a general practitioner in psychiatry, first at Øyane DPS and later at Kronstad DPS, both affiliated with Helse Bergen.